Um Cytologic, inc.

Über das Unternehmen

CytoLogic, Inc., a medical device company, focuses on developing and commercializing a technology for treating cancerous tumors. The company’s UNLEASH therapy, which engages selective filtration of blood plasma on a dialysis-type platform, enhances a cancer patient’s natural immune response to malignant cells. Its UNLEASH technology depletes certain inhibitors of the body’s immune function enabling the patient’s immune system to fight malignant tumors. CytoLogic was founded in 1998 and is based in Boulder, Colorado.